Skip to main content
Top
Published in: Pediatric Nephrology 2/2011

01-02-2011 | Original Article

Age-related stature and linear body segments in children with X-linked hypophosphatemic rickets

Authors: Miroslav Živičnjak, Dirk Schnabel, Heiko Billing, Hagen Staude, Guido Filler, Uwe Querfeld, Marius Schumacher, Anke Pyper, Carmen Schröder, Jürgen Brämswig, Dieter Haffner, Hypophosphatemic Rickets Study Group of the “Arbeitsgemeinschaft für Pädiatrische Endokrinologie” and “Gesellschaft für Pädiatrische Nephrologie”

Published in: Pediatric Nephrology | Issue 2/2011

Login to get access

Abstract

Children with X-linked hypophosphatemic rickets (XLH) are prone to severe stunting. A multicenter mixed-longitudinal study was conducted to assess age-related stature, sitting height, arm and leg length in XLH patients on continuous treatment with phosphate and calcitriol. Mean standard deviation scores (SDS) for all body dimensions were markedly reduced and differed significantly among each other at the initial and subsequent evaluations (baseline: stature −2.48 SDS; sitting height −0.99 SDS; arm length −1.81 SDS; leg length −2.90 SDS; each p < 0.001). A strong association between stature and leg length (r 2= 0.87, p < 0.001) was noted. Leg length SDS decreased progressively during childhood (2–9 years) and adolescence (12–15 years; each p < 0.001). Sitting height SDS increased significantly during late childhood, indicating uncoupled growth of the legs and trunk and resulting in an ever increasing sitting height index (i.e. ratio of sitting height to stature; age 2 years 2.0 SDS; age 10 years 3.3 SDS; p < 0.001) that was associated with the degree of stunting (r 2 = 0.314, p< 0.001). Mean serum phosphate levels were positively associated with stature and leg length, but negatively with sitting height index. Based on these results, we can conclude that growth of the legs and trunk is uncoupled in XLH and related to serum phosphate levels.
Literature
1.
go back to reference Bastepe M, Jüppner H (2008) Inherited hypophosphatemic disorders in children and the evolving mechanisms of phosphate regulation. Rev Endocr Metab Disord 9:171–180CrossRefPubMed Bastepe M, Jüppner H (2008) Inherited hypophosphatemic disorders in children and the evolving mechanisms of phosphate regulation. Rev Endocr Metab Disord 9:171–180CrossRefPubMed
2.
go back to reference The HYP Consortium (1995) A gene (PEX) with homologies to endopeptidases is mutated in patients with X-linked hypophosphatemic rickets. Nat Genet 11:130–136 The HYP Consortium (1995) A gene (PEX) with homologies to endopeptidases is mutated in patients with X-linked hypophosphatemic rickets. Nat Genet 11:130–136
3.
go back to reference Ichikawa S, Traxler EA, Estwick SA, Curry LR, Johnson ML, Sorenson AH, Imel EA, Econs MJ (2008) Mutational survey of the PHEX gene in patients with X-linked hypophosphatemic rickets. Bone 43:663–666CrossRefPubMed Ichikawa S, Traxler EA, Estwick SA, Curry LR, Johnson ML, Sorenson AH, Imel EA, Econs MJ (2008) Mutational survey of the PHEX gene in patients with X-linked hypophosphatemic rickets. Bone 43:663–666CrossRefPubMed
4.
go back to reference Jan de Beur SM, Levine MA (2002) Molecular pathogenesis of hypophosphatemic rickets. J Clin Endocrinol Metab 87:2467–2473CrossRefPubMed Jan de Beur SM, Levine MA (2002) Molecular pathogenesis of hypophosphatemic rickets. J Clin Endocrinol Metab 87:2467–2473CrossRefPubMed
5.
6.
go back to reference Alon US (2006) Hypophosphatemic vitamin-D resistant rickets. In: Favus MJ (ed) Primer on the metabolic bone diseases and disorders of mineral metabolism. American Society of Bone and Mineral Research, Washington D.C., pp 342–345 Alon US (2006) Hypophosphatemic vitamin-D resistant rickets. In: Favus MJ (ed) Primer on the metabolic bone diseases and disorders of mineral metabolism. American Society of Bone and Mineral Research, Washington D.C., pp 342–345
7.
go back to reference Reusz GS, Latta K, Hoyer PF, Byrd DJ, Ehrich JH, Brodehl J (1990) Evidence suggesting hyperoxaluria as a cause of nephrocalcinosis in phosphate-treated hypophosphataemic rickets. Lancet 335:1240–1243CrossRefPubMed Reusz GS, Latta K, Hoyer PF, Byrd DJ, Ehrich JH, Brodehl J (1990) Evidence suggesting hyperoxaluria as a cause of nephrocalcinosis in phosphate-treated hypophosphataemic rickets. Lancet 335:1240–1243CrossRefPubMed
8.
go back to reference Patzer L, van't Hoff W, Shah V, Hallson P, Kasidas GP, Samuell C, de Bruyn R, Barratt TM, Dillon MJ (1999) Urinary supersaturation of calcium oxalate and phosphate in patients with X-linked hypophosphatemic rickets and in healthy schoolchildren. J Pediatr 135:611–617CrossRefPubMed Patzer L, van't Hoff W, Shah V, Hallson P, Kasidas GP, Samuell C, de Bruyn R, Barratt TM, Dillon MJ (1999) Urinary supersaturation of calcium oxalate and phosphate in patients with X-linked hypophosphatemic rickets and in healthy schoolchildren. J Pediatr 135:611–617CrossRefPubMed
9.
go back to reference Kooh SW, Binet A, Daneman A (1994) Nephrocalcinosis in X-linked hypophosphataemic rickets: its relationship to treatment, kidney function, and growth. Clin Invest Med 17:123–130PubMed Kooh SW, Binet A, Daneman A (1994) Nephrocalcinosis in X-linked hypophosphataemic rickets: its relationship to treatment, kidney function, and growth. Clin Invest Med 17:123–130PubMed
10.
go back to reference Schmitt CP, Mehls O (2004) The enigma of hyperparathyroidism in hypophosphatemic rickets. Pediatr Nephrol 19:473–477CrossRefPubMed Schmitt CP, Mehls O (2004) The enigma of hyperparathyroidism in hypophosphatemic rickets. Pediatr Nephrol 19:473–477CrossRefPubMed
11.
go back to reference Berndt M, Ehrich JH, Lazovic D, Zimmermann J, Hillmann G, Kayser C, Prokop M, Schirg E, Siegert B, Wolff G, Brodehl J (1996) Clinical course of hypophosphatemic rickets in 23 adults. Clin Nephrol 45:33–41PubMed Berndt M, Ehrich JH, Lazovic D, Zimmermann J, Hillmann G, Kayser C, Prokop M, Schirg E, Siegert B, Wolff G, Brodehl J (1996) Clinical course of hypophosphatemic rickets in 23 adults. Clin Nephrol 45:33–41PubMed
12.
go back to reference Friedman NE, Lobaugh B, Drezner MK (1993) Effects of calcitriol and phosphorus therapy on the growth of patients with X-linked hypophosphatemia. J Clin Endocrinol Metab 76:839–844CrossRefPubMed Friedman NE, Lobaugh B, Drezner MK (1993) Effects of calcitriol and phosphorus therapy on the growth of patients with X-linked hypophosphatemia. J Clin Endocrinol Metab 76:839–844CrossRefPubMed
13.
go back to reference Glorieux FH, Marie PJ, Pettifor JM, Delvin EE (1980) Bone response to phosphate salts, ergocalciferol, and calcitriol in hypophosphatemic vitamin D-resistant rickets. N Engl J Med 303:1023–1031CrossRefPubMed Glorieux FH, Marie PJ, Pettifor JM, Delvin EE (1980) Bone response to phosphate salts, ergocalciferol, and calcitriol in hypophosphatemic vitamin D-resistant rickets. N Engl J Med 303:1023–1031CrossRefPubMed
14.
go back to reference Haffner D, Weinfurth A, Manz F, Schmidt H, Bremer HJ, Mehls O, Scharer K (1999) Long-term outcome of paediatric patients with hereditary tubular disorders. Nephron 83:250–260CrossRefPubMed Haffner D, Weinfurth A, Manz F, Schmidt H, Bremer HJ, Mehls O, Scharer K (1999) Long-term outcome of paediatric patients with hereditary tubular disorders. Nephron 83:250–260CrossRefPubMed
15.
go back to reference Haffner D, Nissel R, Wuhl E, Mehls O (2004) Effects of growth hormone treatment on body proportions and final height among small children with X-linked hypophosphatemic rickets. Pediatrics 113:e593–e596CrossRefPubMed Haffner D, Nissel R, Wuhl E, Mehls O (2004) Effects of growth hormone treatment on body proportions and final height among small children with X-linked hypophosphatemic rickets. Pediatrics 113:e593–e596CrossRefPubMed
16.
go back to reference Steendijk R, Hauspie RC (1992) The pattern of growth and growth retardation of patients with hypophosphataemic vitamin D-resistant rickets: a longitudinal study. Eur J Pediatr 151:422–427CrossRefPubMed Steendijk R, Hauspie RC (1992) The pattern of growth and growth retardation of patients with hypophosphataemic vitamin D-resistant rickets: a longitudinal study. Eur J Pediatr 151:422–427CrossRefPubMed
17.
go back to reference Verge CF, Lam A, Simpson JM, Cowell CT, Howard NJ, Silink M (1991) Effects of therapy in X-linked hypophosphatemic rickets. N Engl J Med 325:1843–1848CrossRefPubMed Verge CF, Lam A, Simpson JM, Cowell CT, Howard NJ, Silink M (1991) Effects of therapy in X-linked hypophosphatemic rickets. N Engl J Med 325:1843–1848CrossRefPubMed
18.
go back to reference Steendijk R, Herweijer TJ (1984) Height, sitting height and leg length in patients with hypophosphataemic rickets. Acta Paediatr Scand 73:181–184CrossRefPubMed Steendijk R, Herweijer TJ (1984) Height, sitting height and leg length in patients with hypophosphataemic rickets. Acta Paediatr Scand 73:181–184CrossRefPubMed
19.
go back to reference Ariceta G, Langman CB (2007) Growth in X-linked hypophosphatemic rickets. Eur J Pediatr 166:303–309CrossRefPubMed Ariceta G, Langman CB (2007) Growth in X-linked hypophosphatemic rickets. Eur J Pediatr 166:303–309CrossRefPubMed
20.
go back to reference Petersen DJ, Boniface AM, Schranck FW, Rupich RC, Whyte MP (1992) X-linked hypophosphatemic rickets: a study (with literature review) of linear growth response to calcitriol and phosphate therapy. J Bone Miner Res 7:583–597CrossRefPubMed Petersen DJ, Boniface AM, Schranck FW, Rupich RC, Whyte MP (1992) X-linked hypophosphatemic rickets: a study (with literature review) of linear growth response to calcitriol and phosphate therapy. J Bone Miner Res 7:583–597CrossRefPubMed
21.
go back to reference Reusz GS, Hoyer PF, Lucas M, Krohn HP, Ehrich JH, Brodehl J (1990) X linked hypophosphataemia: treatment, height gain, and nephrocalcinosis. Arch Dis Child 65:1125–1128CrossRefPubMed Reusz GS, Hoyer PF, Lucas M, Krohn HP, Ehrich JH, Brodehl J (1990) X linked hypophosphataemia: treatment, height gain, and nephrocalcinosis. Arch Dis Child 65:1125–1128CrossRefPubMed
22.
go back to reference Seikaly MG, Waber PG, Baum M (2008) Urinary prostaglandins and the effect of indomethacin on phosphate excretion in children with hypophosphatemic rickets. Pediatr Res 64:210–212CrossRefPubMed Seikaly MG, Waber PG, Baum M (2008) Urinary prostaglandins and the effect of indomethacin on phosphate excretion in children with hypophosphatemic rickets. Pediatr Res 64:210–212CrossRefPubMed
23.
go back to reference Cho HY, Lee BH, Kang JH, Ha IS, Cheong HI, Choi Y (2005) A clinical and molecular genetic study of hypophosphatemic rickets in children. Pediatr Res 58:329–333CrossRefPubMed Cho HY, Lee BH, Kang JH, Ha IS, Cheong HI, Choi Y (2005) A clinical and molecular genetic study of hypophosphatemic rickets in children. Pediatr Res 58:329–333CrossRefPubMed
24.
go back to reference Hoyer PF (1996) Nephrokalzinose. In: Hofmann V, Deeg KH, Hoyer PF (eds) Ultraschall-diagnostik in Pädiatrie und Kinderchirurgie. Thieme, Stuttgart, New York, pp 372–374 Hoyer PF (1996) Nephrokalzinose. In: Hofmann V, Deeg KH, Hoyer PF (eds) Ultraschall-diagnostik in Pädiatrie und Kinderchirurgie. Thieme, Stuttgart, New York, pp 372–374
25.
go back to reference Weiner JS, Lourie JA (1981) Practical human biology. Academic Press, London Weiner JS, Lourie JA (1981) Practical human biology. Academic Press, London
26.
go back to reference Živičnjak M, Franke D, Filler G, Haffner D, Froede K, Nissel R, Haase S, Offner G, Ehrich JH, Querfeld U (2007) Growth impairment shows an age-dependent pattern in boys with chronic kidney disease. Pediatr Nephrol 22:420–429CrossRefPubMed Živičnjak M, Franke D, Filler G, Haffner D, Froede K, Nissel R, Haase S, Offner G, Ehrich JH, Querfeld U (2007) Growth impairment shows an age-dependent pattern in boys with chronic kidney disease. Pediatr Nephrol 22:420–429CrossRefPubMed
27.
go back to reference Živičnjak M, Narancic NS, Szirovicza L, Franke D, Hrenovic J, Bisof V (2003) Gender-specific growth patterns for stature, sitting height and limbs length in Croatian children and youth (3 to 18 years of age). Coll Antropol 27:321–334PubMed Živičnjak M, Narancic NS, Szirovicza L, Franke D, Hrenovic J, Bisof V (2003) Gender-specific growth patterns for stature, sitting height and limbs length in Croatian children and youth (3 to 18 years of age). Coll Antropol 27:321–334PubMed
28.
go back to reference Zivicnjak M, Smolej Narancic N, Szirovicza L, Franke D, Hrenovic J, Bisof V, Tomas Z, Skaric-Juric T (2008) Gender-specific growth patterns of transversal body dimensions in Croatian children and youth (2 to 18 years of age). Coll Antropol 32:419–431PubMed Zivicnjak M, Smolej Narancic N, Szirovicza L, Franke D, Hrenovic J, Bisof V, Tomas Z, Skaric-Juric T (2008) Gender-specific growth patterns of transversal body dimensions in Croatian children and youth (2 to 18 years of age). Coll Antropol 32:419–431PubMed
29.
go back to reference Kruse K, Hinkel GK, Griefahn B (1998) Calcium metabolism and growth during early treatment of children with X-linked hypophosphataemic rickets. Eur J Pediatr 157:894–900CrossRefPubMed Kruse K, Hinkel GK, Griefahn B (1998) Calcium metabolism and growth during early treatment of children with X-linked hypophosphataemic rickets. Eur J Pediatr 157:894–900CrossRefPubMed
30.
go back to reference Pedersen HE, Mc CH (1951) Vitamin-resistant rickets. J Bone Joint Surg Am 33:203–220PubMed Pedersen HE, Mc CH (1951) Vitamin-resistant rickets. J Bone Joint Surg Am 33:203–220PubMed
31.
go back to reference Imel EA, DiMeglio LA, Hui SL, Carpenter TO, Econs MJ (2010) Treatment of X-linked hypophosphatemia with calcitriol and phosphate increases circulating fibroblast growth factor 23 concentrations. J Clin Endocrinol Metab 95:1846–1850CrossRefPubMed Imel EA, DiMeglio LA, Hui SL, Carpenter TO, Econs MJ (2010) Treatment of X-linked hypophosphatemia with calcitriol and phosphate increases circulating fibroblast growth factor 23 concentrations. J Clin Endocrinol Metab 95:1846–1850CrossRefPubMed
32.
go back to reference Wesseling-Perry K, Pereira RC, Wang H, Elashoff RM, Sahney S, Gales B, Juppner H, Salusky IB (2009) Relationship between plasma fibroblast growth factor-23 concentration and bone mineralization in children with renal failure on peritoneal dialysis. J Clin Endocrinol Metab 94:511–517CrossRefPubMed Wesseling-Perry K, Pereira RC, Wang H, Elashoff RM, Sahney S, Gales B, Juppner H, Salusky IB (2009) Relationship between plasma fibroblast growth factor-23 concentration and bone mineralization in children with renal failure on peritoneal dialysis. J Clin Endocrinol Metab 94:511–517CrossRefPubMed
34.
go back to reference Gaucher C, Walrant-Debray O, Nguyen TM, Esterle L, Garabedian M, Jehan F (2009) PHEX analysis in 118 pedigrees reveals new genetic clues in hypophosphatemic rickets. Hum Genet 125:401–411CrossRefPubMed Gaucher C, Walrant-Debray O, Nguyen TM, Esterle L, Garabedian M, Jehan F (2009) PHEX analysis in 118 pedigrees reveals new genetic clues in hypophosphatemic rickets. Hum Genet 125:401–411CrossRefPubMed
35.
go back to reference Ruchon AF, Tenenhouse HS, Marcinkiewicz M, Siegfried G, Aubin JE, DesGroseillers L, Crine P, Boileau G (2000) Developmental expression and tissue distribution of Phex protein: effect of the Hyp mutation and relationship to bone markers. J Bone Miner Res 15:1440–1450CrossRefPubMed Ruchon AF, Tenenhouse HS, Marcinkiewicz M, Siegfried G, Aubin JE, DesGroseillers L, Crine P, Boileau G (2000) Developmental expression and tissue distribution of Phex protein: effect of the Hyp mutation and relationship to bone markers. J Bone Miner Res 15:1440–1450CrossRefPubMed
36.
go back to reference Ecarot B, Glorieux FH, Desbarats M, Travers R, Labelle L (1995) Effect of 1, 25-dihydroxyvitamin D3 treatment on bone formation by transplanted cells from normal and X-linked hypophosphatemic mice. J Bone Miner Res 10:424–431CrossRefPubMed Ecarot B, Glorieux FH, Desbarats M, Travers R, Labelle L (1995) Effect of 1, 25-dihydroxyvitamin D3 treatment on bone formation by transplanted cells from normal and X-linked hypophosphatemic mice. J Bone Miner Res 10:424–431CrossRefPubMed
37.
go back to reference Holm IA, Nelson AE, Robinson BG, Mason RS, Marsh DJ, Cowell CT, Carpenter TO (2001) Mutational analysis and genotype-phenotype correlation of the PHEX gene in X-linked hypophosphatemic rickets. J Clin Endocrinol Metab 86:3889–3899CrossRefPubMed Holm IA, Nelson AE, Robinson BG, Mason RS, Marsh DJ, Cowell CT, Carpenter TO (2001) Mutational analysis and genotype-phenotype correlation of the PHEX gene in X-linked hypophosphatemic rickets. J Clin Endocrinol Metab 86:3889–3899CrossRefPubMed
38.
go back to reference Jehan F, Gaucher C, Nguyen TM, Walrant-Debray O, Lahlou N, Sinding C, Dechaux M, Garabedian M (2008) Vitamin D receptor genotype in hypophosphatemic rickets as a predictor of growth and response to treatment. J Clin Endocrinol Metab 93:4672–4682CrossRefPubMed Jehan F, Gaucher C, Nguyen TM, Walrant-Debray O, Lahlou N, Sinding C, Dechaux M, Garabedian M (2008) Vitamin D receptor genotype in hypophosphatemic rickets as a predictor of growth and response to treatment. J Clin Endocrinol Metab 93:4672–4682CrossRefPubMed
39.
go back to reference Baroncelli GI, Bertelloni S, Ceccarelli C, Saggese G (2001) Effect of growth hormone treatment on final height, phosphate metabolism, and bone mineral density in children with X-linked hypophosphatemic rickets. J Pediatr 138:236–243CrossRefPubMed Baroncelli GI, Bertelloni S, Ceccarelli C, Saggese G (2001) Effect of growth hormone treatment on final height, phosphate metabolism, and bone mineral density in children with X-linked hypophosphatemic rickets. J Pediatr 138:236–243CrossRefPubMed
40.
go back to reference Haffner D, Wuhl E, Blum WF, Schaefer F, Mehls O (1995) Disproportionate growth following long-term growth hormone treatment in short children with X-linked hypophosphataemia. Eur J Pediatr 154:610–613CrossRefPubMed Haffner D, Wuhl E, Blum WF, Schaefer F, Mehls O (1995) Disproportionate growth following long-term growth hormone treatment in short children with X-linked hypophosphataemia. Eur J Pediatr 154:610–613CrossRefPubMed
41.
go back to reference Seikaly MG, Brown R, Baum M (1997) The effect of recombinant human growth hormone in children with X-linked hypophosphatemia. Pediatrics 100:879–884CrossRefPubMed Seikaly MG, Brown R, Baum M (1997) The effect of recombinant human growth hormone in children with X-linked hypophosphatemia. Pediatrics 100:879–884CrossRefPubMed
42.
go back to reference Alon US, Levy-Olomucki R, Moore WV, Stubbs J, Liu S, Quarles LD (2008) Calcimimetics as an adjuvant treatment for familial hypophosphatemic rickets. Clin J Am Soc Nephrol 3:658–664CrossRefPubMed Alon US, Levy-Olomucki R, Moore WV, Stubbs J, Liu S, Quarles LD (2008) Calcimimetics as an adjuvant treatment for familial hypophosphatemic rickets. Clin J Am Soc Nephrol 3:658–664CrossRefPubMed
Metadata
Title
Age-related stature and linear body segments in children with X-linked hypophosphatemic rickets
Authors
Miroslav Živičnjak
Dirk Schnabel
Heiko Billing
Hagen Staude
Guido Filler
Uwe Querfeld
Marius Schumacher
Anke Pyper
Carmen Schröder
Jürgen Brämswig
Dieter Haffner
Hypophosphatemic Rickets Study Group of the “Arbeitsgemeinschaft für Pädiatrische Endokrinologie” and “Gesellschaft für Pädiatrische Nephrologie”
Publication date
01-02-2011
Publisher
Springer-Verlag
Published in
Pediatric Nephrology / Issue 2/2011
Print ISSN: 0931-041X
Electronic ISSN: 1432-198X
DOI
https://doi.org/10.1007/s00467-010-1705-9

Other articles of this Issue 2/2011

Pediatric Nephrology 2/2011 Go to the issue